Literature DB >> 11819663

Design, delivery and efficacy testing of therapeutic nucleic acidsused to inhibit hepatitis C virus gene expression in vitro and in vivo.

Wolfgang H Caselmann, Matthias Serwe, Thomas Lehmann, Jnos Ludwig, Brian S Sproat, Joachim W Engels.   

Abstract

Entities:  

Year:  2000        PMID： 11819663      PMCID： PMC4688832          DOI： 10.3748/wjg.v6.i5.626

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  7 in total

1.  Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation.

Authors:  M Alt; R Renz; P H Hofschneider; W H Caselmann
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

2.  Extending the cleavage rules for the hammerhead ribozyme: mutating adenosine15.1 to inosine15.1 changes the cleavage site specificity from N16.2U16.1H17 to N16.2C16.1H17.

Authors:  J Ludwig; M Blaschke; B S Sproat
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

Review 3.  Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.

Authors:  W H Caselmann; S Eisenhardt; M Alt
Journal:  Intervirology       Date:  1997       Impact factor: 1.763

4.  Combination therapy of chronic hepatitis C: an important step but not the final goal!

Authors:  H Wedemeyer; W H Caselmann; M P Manns
Journal:  J Hepatol       Date:  1998-12       Impact factor: 25.083

5.  Mutational analysis of two unstructured domains of the 5' untranslated region of HCV RNA.

Authors:  A Varaklioti; U Georgopoulou; A Kakkanas; L Psaridi; M Serwe; W H Caselmann; P Mavromara
Journal:  Biochem Biophys Res Commun       Date:  1998-12-30       Impact factor: 3.575

6.  Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation.

Authors:  M Alt; S Eisenhardt; M Serwe; R Renz; J W Engels; W H Caselmann
Journal:  Eur J Clin Invest       Date:  1999-10       Impact factor: 4.686

7.  Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.

Authors:  M Alt; R Renz; P H Hofschneider; G Paumgartner; W H Caselmann
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425
  7 in total
  3 in total

1.  Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes.

Authors:  H C Zhou; D Z Xu; X P Wang; J X Zhang; Y Huang; Y P Yan; Y Zhu; B Q Jin
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistry.

Authors:  Yan-Wei Zhong; Jun Cheng; Gang Wang; Shuang-Shuang Shi; Li Li; Ling-Xia Zhang; Ju-Mei Chen
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Sequence evolution of putative cytotoxic T cell epitopes in NS3 region of hepatitis C virus.

Authors:  Hua-Zhang Guo; Ying Yin; Wen-Liang Wang; Chuan-Shan Zhang; Tao Wang; Zhe Wang; Jing Zhang; Hong Cheng; Hai-Tao Wang
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.